Are these tests a choice that is wise?
10 years ago, organizations started developing saliva-based, at-home hereditary tests that provide individuals the capability to find out about their traits that are genetic. These tests started with ancestry information, then developed to add faculties (such as hair loss and locks color), predispositions for health problems (such as for instance Parkinson’s condition and cancer of the breast), and reactions to specific prescription drugs. These “direct-to-consumer” (DTC) tests provide fast, affordable hereditary screening without the need to consult with a physician… But is this a choice that is wise? And exactly how if the outcomes be interpreted and used?
Understand the restrictions: mail-order tests are neither comprehensive nor definitive
In March 2018, the usa Food and Drug management authorized DTC business 23andMe to report on dangers linked to the BRCA2 and BRCA1 genes. These genes had been catapulted to fame in 2013 by Angelina Jolie, whom opened about her experience and choices that are preventative a provider of a BRCA1 mutation. The BRCA1/2 genes are connected with a risk that is high breast and ovarian cancer tumors, and mildly increased dangers for any other cancers. Continue reading